» Articles » PMID: 19360249

Ventricular Remodeling After Myocardial Infarction: Concepts and Clinical Implications

Overview
Date 2009 Apr 11
PMID 19360249
Citations 35
Authors
Affiliations
Soon will be listed here.
Citing Articles

Therapeutic peptides for coronary artery diseases: in silico methods and current perspectives.

Aslan A, Ari Yuka S Amino Acids. 2024; 56(1):37.

PMID: 38822212 PMC: 11143054. DOI: 10.1007/s00726-024-03397-3.


The role of periostin in cardiac fibrosis.

Qiao B, Liu X, Wang B, Wei S Heart Fail Rev. 2023; 29(1):191-206.

PMID: 37870704 DOI: 10.1007/s10741-023-10361-y.


The let-7b-5p, miR-326, and miR-125a-3p are associated with left ventricular systolic dysfunction in post-myocardial infarction.

Dantas-Komatsu R, Cruz M, Paccielli Freire P, Viana Zuza Diniz R, Bortolin R, Cabral-Marques O Front Cardiovasc Med. 2023; 10:1151855.

PMID: 37252118 PMC: 10218134. DOI: 10.3389/fcvm.2023.1151855.


Short-term efficacy of angiotensin receptor-neprilysin inhibitor treatment in patients with ST-segment elevation myocardial infarction with reduced ejection fraction after primary percutaneous coronary intervention: a propensity score matching study.

Zhang Q, Qiao B, Han Y, Sun S, Wang B, Wei S BMC Cardiovasc Disord. 2022; 22(1):463.

PMID: 36333668 PMC: 9636690. DOI: 10.1186/s12872-022-02906-0.


A systematic review and meta-analysis of sacubitril-valsartan in the treatment of ventricular remodeling in patients with heart failure after acute myocardial infarction.

Zhou X, Zhu H, Zheng Y, Tan X, Tong X Front Cardiovasc Med. 2022; 9:953948.

PMID: 36304540 PMC: 9592716. DOI: 10.3389/fcvm.2022.953948.